Rare diseases
Investigational molecules
Locations
Back to France66 clinical trials in Garches, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of REGN7544 for Treating Adults with Low Blood Pressure Caused by Sepsis
FranceStudy on Ivabradine for Heart Rate Control and Survival in Adults with Septic Shock
FranceStudy on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis
FranceStudy on the Effectiveness and Safety of NT 201 (Botulinum Toxin) for Treating Lower Limb Spasticity in Adults After Stroke or Traumatic Brain Injury
FranceLong-term Safety Study of Onasemnogene Abeparvovec for Patients with Spinal Muscular Atrophy
FranceStudy on Voxelotor for Reducing Hemolysis in Patients with Sickle Cell Disease
FranceStudy on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy
FranceStudy on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy
FranceStudy of hydrocortisone and fludrocortisone combination versus placebo in adults with sepsis in intensive care unit to determine corticosteroid response
FranceStudy on Long-Term Safety of Oral Lucerastat for Adults with Fabry Disease
FranceStudy on Dexamethasone and Sodium Chloride for Treating Severe Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
FranceStudy on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on innovative treatments for neuromuscular conditions and movement disorders, including studies on Spinal Muscular Atrophy and Myasthenia Gravis. Research examines novel drug delivery systems and therapeutic approaches for improving patient outcomes.
Groundbreaking research in intensive care focusing on treating severe conditions like septic shock and immunosuppression. Studies evaluate new therapeutic approaches for improving survival rates and patient outcomes in critical care settings.
Innovative clinical trials targeting rare genetic conditions including Pompe Disease and Fabry Disease. Research focuses on enzyme replacement therapies and novel treatment approaches to improve patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
